表紙
市場調査レポート

世界の家畜医療市場:製品別、診断技術別、動物別、地域別 - 動向および予測

Farm Animal Healthcare Market By Products , By Diagnostic Technologies, By Animal Type, By Geography - Trends And Forecasts (2014-2019)

発行 Mordor Intelligence LLP 商品コード 319395
出版日 ページ情報 英文 58 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
世界の家畜医療市場:製品別、診断技術別、動物別、地域別 - 動向および予測 Farm Animal Healthcare Market By Products , By Diagnostic Technologies, By Animal Type, By Geography - Trends And Forecasts (2014-2019)
出版日: 2016年03月01日 ページ情報: 英文 58 Pages
概要

世界の家畜医療市場は、2014年に134億6,000万米ドルになると予測されています。同市場は今後もCAGR8.25%で成長しつづけ、2018年には202億米ドルに達するとみられています。

当レポートでは、世界の家畜医療市場の現状と将来予測、セグメント別、地域別動向とともに、主要な参入企業の競合環境とプロファイルなどをまとめています。

第1章 イントロダクション

第2章 市場分析

  • 動物医療製品
  • 動物医療と人間医療

第3章 市場動向

  • 市場促進因子
    • ペットオーナーシップ
    • 栄養の改善
    • 消費者が食品の安全性への注意を高めている
    • 飼料の増産
    • 動物原性感染病および食物経由の疾患
  • 市場阻害因子
    • 耕作地と水の危機
    • 耕作地の競争激化
    • 費用対効果の高い生産
  • ポーターズファイブフォース分析

第4章 市場セグメンテーション

  • 製品別
    • 寄生虫駆除剤
    • 抗炎症薬
    • 医療用食品添加物
    • その他の医薬品
    • ワクチン
  • 家畜

第5章 世界の家畜診断薬市場

  • 酵素結合免疫吸着検査法
  • 即時免疫移動
  • 寒天ゲル免疫核酸法

第6章 世界の家畜遺伝学市場

第7章 地域別市場セグメンテーション

  • 北米
  • 欧州
  • アジア太平洋地域

第8章 競合環境

  • 市場における主要企業
  • 合併・買収
  • 新製品上市
  • 協定、連携、パートナーシップ

第9章 企業プロファイル

  • Zoetis animal healthcare
  • Merck
  • Merial
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第10章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Growing numbers of farm animals, increasing use of intensive animal husbandry practices and rising incidence of chronic diseases in animals have propelled the need for better animal healthcare. Food safety concerns have boosted the need for better healthcare for farm animals.

The market for animal healthcare for farm animals is estimated to be worth $13.46 billion in 2014. Expected to grow at a CAGR of 8.25%, the market is set to reach $20.2 billion by 2018.

The rapidly increasing human population has put an emphasis on adequate and reliable supply of food products, especially animal food products. Major constraints for the market are increasing competition for cultivated land and scarcity of arable land, which in turn affects farm production.

The farm animal health market is segmented based on type of products (Vaccines, Paraciticides, Anti-infectives, Medicinal feed additives, and other pharmaceuticals), based on diagnostics (Enzyme Linked Immuno sorbent assay(ELISA), Rapid Immuno Migration( RIM)) and based on genetics. By geography, the market is divided into North America, Asia-Pacific, Europe and Rest of World. Europe accounts for the largest share of the animal vaccines market, followed by North America. The developing regions like Asia-pacific and Africa are expected to form a new revenue pocket in the market. Countries such as India, China, Brazil will be the major contributors in the market.

What makes our report unique

  • 1) In depth analysis of current market trends and future forecasts of the market based on different products available for both companion animals and farm animals
  • 2) We provide longest possible market segmentation of the market based on products available, diagnostics, genetics , and geography. We give you the competitive landscape for the market which provides information about major players in the market, Market Share and recent developments.
  • 3) High level analysis on products i.e Vaccines, anti-infectants, MFA, Paraciticides and introduced novel vaccines such as DNA and recombinant vaccines.

Table of Contents

1.INTRODUCTION

  • 1.1. Market Definition
  • 1.2. Market Recent Trend

2. Market Analysis

  • 2.1. Market Animal Health Products
  • 2.2. Animal medicines vs human Medicines

3. Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increase in pet ownership
    • 3.1.2. Improved Nutrition
    • 3.1.3. Intensifying consumer focus on food safety
    • 3.1.4. Greater Livestock production
    • 3.1.5. Increasing Zoonotic and Foodborne Diseases
  • 3.2. Market Constraints
    • 3.2.1. Scarcity of arable land and water
    • 3.2.2. Increased competition for cultivated land
    • 3.2.3. Cost effective production
  • 3.3. Porter's Five Force Analysis
    • 3.3.1. Threat of New Entrant
    • 3.3.2. Internal Rivalry
    • 3.3.3. Buyer bargaining power
    • 3.3.4. Supplier bargaining power
    • 3.3.5. Threat of substitutes

4. Global Farm Animal Market Segmentation -By products

  • 4.1. Farm Animals
    • 4.1.1. Vaccines
    • 4.1.2. Paraciticides
    • 4.1.3. Anti-Infectives
    • 4.1.4. Medicinal Feed additives
    • 4.1.5. Other Pharmaceuticals
  • 4.2. Farm animal
    • 4.2.1Cattle
    • 4.2.2. Swine
    • 4.2.3. Poultry
    • 4.2.4. Fish
    • 4.2.5. Sheep

5. Global Farm Animal Diagnostics Market

    • 5.1.1. Enzyme Linked Immuno Sorbent Assay( ELISA)
    • 5.1.2. Rapid Immuno Migration( RIM)
    • 5.1.3. Agar gel Immuno Diffusion( AGID)

6. Global Farm Animal Genetics Market

  • 6.1. HD 50K for Angus
  • 6.2. CLARIFIDE for Dairy
  • 6.3. Sheep 50K
  • 6.4. CLARIFIDE for Nelore
  • 6.5. Others

7.Global Farm Animal Market Segmentation, By Geography

  • 7.1. North America
    • 7.1.1. US
    • 7.1.2. Mexico
    • 7.1.3Canada
  • 7.2. Europe
    • 7.2.1. France
    • 7.2.2. Italy
    • 7.2.3. Germany
    • 7.2.4. Spain
    • 7.2.5. Italy
  • 7.3. Asia-Pacific
    • 7.3.1India
    • 7.3.2. China
    • 7.3.3. Japan

8. Competitive landscape

  • 8.1. Major players in the market
  • 8.2. Mergers and acquisitions
  • 8.3. New product launches
  • 8.4. Agreement, Collaborations and Partnerships

9.Company profiles

  • 9.1. Zoetis animal healthcare
    • 9.1.1. Financial Overview
    • 9.1.2. Business overview
    • 9.1.3. Business strategies
  • 9.2. Merck
    • 9.2.1Financial Overview
    • 9.2.2. Business overview
    • 9.2.3. Business strategies
  • 9.3. Merial (Animal Health Division Of Sanofi)
    • 9.3.1. Financial Overview
    • 9.3.2. Business overview
    • 9.3.3. Business strategies
  • 9.4. Elanco
    • 9.4.1Financial Overview
    • 9.4.2. Business overview
    • 9.4.3. Business strategies
  • 9.5. Bayer healthcare
    • 9.5.1. Financial Overview
    • 9.5.2. Business overview
    • 9.5.3. Business strategies
  • 9.6. Novartis Animal Health, Inc.
    • 9.6.1. Financial Overview
    • 9.6.2. Business overview
    • 9.6.3. Business strategies
  • 9.7. Virbac
    • 9.7.1. Financial Overview
    • 9.7.2. Business overview
    • 9.7.3. Business strategies
  • 9.8. Boehringer Ingelheim
    • 9.8.1. Financial Overview
    • 9.8.2. Business overview
    • 9.8.3. Business strategies

10. Appendix

  • 10.1. Abbreviations
  • 10.2. Sources
  • 10.3. Bibliography
  • 10.4. Disclaimer
Back to Top